atherosclerosis occlusive heart disease
Conditions
Interventions
None listed
Sponsors
Academisch Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Male sex, or postmenopausal female, age 50 years or older
Exclusion criteria
Exclusion criteria: Other disease Medication use (Other) cardiovascular risk factors
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - hsCRP - coagulation - thrombin generation: F1+2 - fibrinolytic system: D-dimers, PAI-1, tPA - endothelial cell activation: vWF - inflammation - monocytic expression of CD11b, CD18, TF, CD62L - cytokines: IL-6, IL-8, TNFalpha (receptor) - chemokines: MCP-1, E-selectin - sunendothelium: MMP-9, MPO | — |
Secondary
| Measure | Time frame |
|---|---|
| - | — |
Countries
Netherlands
Outcome results
None listed